Lv3
300 积分 2024-06-21 加入
Cancer incidence and mortality in China, 2022
1个月前
已完结
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol
3个月前
已完结
Febuxostat administration for the prevention of tumour lysis syndrome: A meta‐analysis
5个月前
已完结
Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study
8个月前
已完结
Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study
9个月前
已完结
Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies
10个月前
已完结
Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions
10个月前
已完结
Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymphoma in Four European Countries
10个月前
已完结
皖公网安备34019202002308
